Heineken Names JDE Peet’s CEO Rafael Oliveira as New Chief Executive 
Cerebras Revenue Forecast Tops Expectations, but Margin Concerns Weigh on Stock 
FedEx Stock Drops After Weak 2026 Earnings Forecast Despite Strong Q4 Results 
100+ Global Companies Push Governments to Prioritize Electrification for Economic Growth 
NTSB Investigates Boston Logan Airport Near-Miss Between Delta and American Airlines Jets 
Meta Pauses Employee Activity Tracking Program Over Data Security Concerns 
KPMG Australia Chairman and Senior Partners Exit Amid Escalating Whistleblower Scandal 
Tesla and NatPower Partner on $5 Billion Battery Storage Expansion in Europe 
Tencent Reviews Marvelous Stake as Gaming Giant Reassesses Global Investment Strategy 
China Adds MP Materials, USA Rare Earth to Export Control List Amid Escalating U.S.-China Trade Tensions 
SpaceX Stock Rebounds After Sharp Selloff, But Valuation Concerns Persist 
Alphabet Stock Slides as AI Talent Exodus and SpaceX Losses Shake Investor Confidence 
NHTSA Investigates Fatal Tesla Model 3 Crash in Texas Amid Ongoing Autopilot and FSD Safety Scrutiny 
California Drivers Sue BP, Walmart, 7-Eleven Over Alleged AI Gas Price Fixing 
Baseten Secures $1.5 Billion Funding at $13 Billion Valuation Amid AI Infrastructure Boom 
Google’s Open-Source AI Data Center Cooling Design Raises Commoditization Concerns 
Oracle Cuts 21,000 Jobs as AI Reshapes Workforce and Cloud Expansion Accelerates 
TEANECK, N.J., Feb. 08, 2016 -- The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.10 per share on its Class A common stock and Class B common stock, payable on March 23, 2016, to stockholders of record at the close of business on March 2, 2016.
About Phibro Animal Health Corporation
Phibro Animal Health Corporation is a diversified global developer, manufacturer and marketer of a broad range of animal health and mineral nutrition products for use in the production of poultry, swine, cattle, dairy and aquaculture. The company reported net sales of $749 million for the fiscal year ended June 30, 2015. For further information, please visit www.pahc.com.
Contact: Richard Johnson Chief Financial Officer, Phibro Animal Health Corporation +1 201-329-7300 [email protected]
